z-logo
open-access-imgOpen Access
The Need for Continued Development of Ricin Countermeasures
Author(s) -
Ronald B. Reisler,
Leonard A. Smith
Publication year - 2012
Publication title -
advances in preventive medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-3499
pISSN - 2090-3480
DOI - 10.1155/2012/149737
Subject(s) - ricin , medicine , computer security , computer science , microbiology and biotechnology , biology , toxin
Ricin toxin, an extremely potent and heat-stable toxin produced from the bean of the ubiquitous Ricinus communis (castor bean plant), has been categorized by the US Centers for Disease Control and Prevention (CDC) as a category B biothreat agent that is moderately easy to disseminate. Ricin has the potential to be used as an agent of biological warfare and bioterrorism. Therefore, there is a critical need for continued development of ricin countermeasures. A safe and effective prophylactic vaccine against ricin that was FDA approved for “at risk” individuals would be an important first step in assuring the availability of medical countermeasures against ricin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom